Esteban Gomez
Pediatric Hematology-Oncology · Orange, CANPI 1992900641
Payments from drug & device makers
Across 168 payments — averaging $1610.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bioverativ Therapeutics Inc.$157K
- Sanofi US Services Inc.$47K
- CSL Behring$16K
- Sanofi$16K
- Takeda Pharmaceuticals U.S.A., Inc.$9K
- Global Blood Therapeutics, Inc.$8K
- plus $18K from 20 others
What the payments were for
- Consulting fees$26,36547%
- Speaking & faculty fees$21,91439%
- Travel & lodging$4,3498%
- Food & beverage$2,8145%
- Education$660%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bioverativ Therapeutics Inc. | 26 | $157,429 |
| Sanofi US Services Inc. | 18 | $46,536 |
| CSL Behring | 20 | $16,205 |
| Sanofi | 22 | $15,698 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $8,593 |
| Global Blood Therapeutics, Inc. | 13 | $8,429 |
| Genentech USA, Inc. | 6 | $6,464 |
| Shire North American Group Inc | 1 | $2,500 |
| Bayer | 4 | $2,277 |
| Chiesi USA, Inc. | 3 | $2,130 |
| Alnylam Pharmaceuticals Inc. | 2 | $1,535 |
| Novartis | 8 | $1,346 |
| Biomarin Pharmaceutical Inc. | 7 | $269 |
| AstraZeneca | 1 | $175 |
| Spark Therapeutics, Inc. | 3 | $165 |
| Novo Nordisk | 5 | $132 |
| Genentech, Inc. | 4 | $127 |
| Portola Pharmaceuticals, LLC | 1 | $125 |
| Agios Pharmaceuticals, Inc. | 5 | $121 |
| HEMA Biologics, LLC | 2 | $86 |
| Pfizer | 3 | $56 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $56 |
| Vertex | 2 | $40 |
| Boston Scientific | 1 | $28 |
| Bio Products Laboratory USA, Inc. | 1 | $23 |
| Genetix Biotherapeutics Inc | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$270,566 in reported general payments places this provider in the 75th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TavalisseFostamatinib Disodium | 12 | $179,595 |
| Deferasirox | 52 | $123,754 |
| XareltoRivaroxaban | 17 | $24,529 |
Paid to pharmacies, not to this prescriber.
Other pediatric hematology-oncology in Orange
- Elyssa RubinOrange$1.1M
- van HuynhOrange$996K
- Mariko SatoOrange$694K
- Diane NugentOrange$652K
- Vanessa Salinas-LunaOrange$538K
- Beth WingerSan Francisco$8.6M
- James GellerSan Diego$7.8M
- Norman LacayoPalo Alto$5M
- Alan WayneLos Angeles$3.8M
- Ami ShahPalo Alto$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.